Pharmacokinetics of weekly low dose doxorubicin
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2) , 191-195
- https://doi.org/10.1016/0277-5379(89)90007-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patientsCancer Chemotherapy and Pharmacology, 1987
- Cellular and plasma pharmacokinetics of weekly 20-mg 4?-epi-adriamycin bolus injection in patients with advanced breast carcinomaCancer Chemotherapy and Pharmacology, 1986
- How much does liver disease affect the pharmacokinetics of adriamycin?European Journal of Cancer and Clinical Oncology, 1985
- Optimal schedule for anthracyclinesEuropean Journal of Cancer and Clinical Oncology, 1985
- Pharmacokinetic study of IV infusions of adriamycinEuropean Journal of Clinical Pharmacology, 1985
- Reduced Cardiotoxicity of Doxorubicin Delivered on a Weekly ScheduleAnnals of Internal Medicine, 1983
- Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitroBritish Journal of Cancer, 1980
- Extraction of Anthracyclines from Biological Fluids for HPLC EvaluationJournal of Liquid Chromatography, 1980
- Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicityCancer, 1977
- PLASMA PHARMACOKINETICS OF ADRIAMYCIN AND ITS METABOLITES IN HUMANS WITH NORMAL HEPATIC AND RENAL-FUNCTION1977